Drug makers Moderna and Pfizer announced this week that early test results show their respective COVID-19 vaccines to be more than 90% effective. Now, both are on track to request emergency authorization from the FDA. But even as scientists race to roll out a vaccine, there are questions about the diversity of the test subjects. Soledad O’Brien speaks with Dr. James E. K. Hildreth, one of the nation’s leading immunologists and head of the Meharry Medical College in Nashville.
End of the Pandemic or The Start of Something Else?
January 16, 2022End of the Pandemic or The Start of Something Else?
January 16, 2022
How West Virginia Went From First to the Bottom in Vaccination Rates
December 5, 2021How West Virginia Went From First to the Bottom in Vaccination Rates
December 5, 2021
How the Pandemic Could Erase Decades of Progress for Women in the Workforce
November 14, 2021How the Pandemic Could Erase Decades of Progress for Women in the Workforce
November 14, 2021
COVID Patients are Checking Out, But Hospitals are Still Overwhelmed
November 7, 2021COVID Patients are Checking Out, But Hospitals are Still Overwhelmed
November 7, 2021
The Cranberry Farmer Taking Charge in a Male Dominated Industry
November 7, 2021The Cranberry Farmer Taking Charge in a Male Dominated Industry
November 7, 2021
How A New York City Restaurant is Coming Back After Letting Go of its Staff
October 17, 2021How A New York City Restaurant is Coming Back After Letting Go of its Staff
October 17, 2021
Rural Americans are Twice as Likely to Die From COVID Than Those in Urban Areas
October 10, 2021Rural Americans are Twice as Likely to Die From COVID Than Those in Urban Areas
October 10, 2021
COVID-19 is Now the Deadliest Disease in U.S. History
October 3, 2021COVID-19 is Now the Deadliest Disease in U.S. History
October 3, 2021
